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ABSTRACT

An experiment was performed to examine the effects of
elevated concentrations of prostaglandin F20, (PGF2a)on

embryonic development in cows supplemented with exogenous
progestogen. Cows were inseminated artificially at estrus
(day 0) and 12 h later. A synthetic progestogen

(melengestrol acetate; 4 mg/cowday"^) was supplemented in
feed from days 3 through 8. Cows were allotted randomly to
receive either 15 mg PGF20 (TRT; n=14) or saline (CON; n=10)
at 0600, 1400 and 2200 h from days 5 through 8. Blood

samples were collected at 0600 and 2200 h from days 5 day 8
for determination of progesterone and 13,14-dihydro-15-k;eto-

PGF2C, (PGFM). Single embryos were recovered on day 8 by
flushing the uterine horn ipsilateral to the corpus luteum
(CL) as determined by ultrasonography on day 5. Each embryo

was assigned a quality score of 1 (excellent) to 4 (poor),
and stage of embryo development was recorded.
Concentrations of progesterone were lower from days 5 to 8
in TRT versus CON cows (0.3 ± 0.14 vs 2.01 ± 0.16 ng/mL,

respectively; P=0.0001). Overall, PGFM concentrations from

days 5 to 8 were elevated in TRT cows (553.2 ± 42.1 pg/mL)
compared to CON cows (13.2 + 50.1 pg/mL; P=0.0001). Embryo
quality scores were elevated in TRT cows compared to CON
cows (2.9 vs 1.6, respectively; P=0.059). Percentage of
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embryos considered transferrable (quality scores 1, 2, and
3) was decreased by administration of PGF2„

(Fisher's exact

test, P=0.003). Nine of fourteen (64%) TRT embryos were

retarded in development at day 8, whereas four of fourteen
(29%) TRT embryos developed to expanded blastocyst. All CON

embryos developed beyond the morula stage; eight of ten
(80%) developed to the expanded blastocyst and two of ten
(20%) reached the blastocyst stage upon recovery (Fisher's
exact test, P=0.003).

In conclusion, treatment of progestogen-supplemented cows
with PGF2a reduced quality and retarded development of embryos
prior to the blastocyst. Decreased fertility in conditions
elevating PGFM concentrations may be a result of retarded
development or reduced quality by PGF20,.
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1. INTRODUCTION

Reproductive efficiency of beef and dairy cattle is a

primary concern of producers and managers. Beef cattle must
wean a calf annually to be profitable. Dairy cows must have

a calving interval that allows a maximum amount of time be
spent in peak milk production.

Embryonic death may occur at any time during
development; however, studies indicated that the greatest

percentage of embryonic mortality occurred prior to day 8 of
gestation (Ayalon, 1978; Maurer and Chenault, 1983). Causes
of embryonic loss include luteal dysfunction and embryonic
chromosomal abnormalities. Studies have shown deleterious

effects of PGFzc on early embryonic survival when
administered on days 5 through 8 after mating in

progestogen-supplemented cows (Buford et al., 1996;
Hernandez —Fonseca et al., 1997; Seals et al., 1998). These

same studies suggested that the regressing corpus luteum

(CL) may be producing an embryotoxic factor(s) since

lutectomy immediately prior to PGF2„ treatment prevented
embryonic loss. A subsequent study by Lemaster et al. (1998)
indicated that the embryotoxin from the regressing CL was

oxytocin (OT) which acted indirectly through increasing
uterine concentrations of PGF2a.

Prostaglandin F20, may be released during uterine

manipulation (Sequin et al., 1974), heat stress (Malayer et
al., 1990), and following exogenous oxytocin administration
to increase milk letdown and production (Newcomb et al.,

1977; Farin and Estill, 1993). Furthermore, concentrations

of PGF20, are increased in cattle grazing endophyte-infected
tall fescue (Seals et al., 1998). Elevated uterine

concentrations of PGF2C, have been associated with reduced

embryo quality and survival (Schrick et al., 1993). In vitro
studies have indicated a direct, negative effect of PGF2C on

development of rabbit and rat 8-cell embryos (Maurer and
Beier, 1976; Breuel et al., 1993a). Day 7 frozen-thawed
bovine embryos cultured in varying concentrations of PGF2a
exhibited no decrease in development to the blastocyst stage

(Fazio and Schrick, 1997). However, extremely high
concentrations of PGF2e, (10 ng/ml) did inhibit development

to expanded/hatched blastocyst. Subsequent in vivo studies
narrowed the "window" of PGF2C susceptibility prior to day 7

after mating (Hernandez-Fonseca et al., 1997; E. K. Inskeep,
personal communication).
These results suggest that the time when embryos are
sensitive to the detrimental effects of PGF2C, is prior to

blastocyst development. Therefore, the objective of the
current study was to administer PGF2a to progestogen-

supplemented cows from days 5-8 postmating and evaluate
developmental stage and quality of embryos flushed from the
uterus on day 8 compared to control cows receiving saline
only.

2. LITERATURE REVIEW

Embryonic development

During a normal estrous cycle, the luteinizing hormone
(LH) surge initiates resumption of meiosis, maturation and
release of the oocyte from the dominant follicle(s) (as

reviewed by Espey, 1994). Following fertilization, embryonic

development begins in the oviduct. The oviduct consists of
four distinct regions: infundibulum, ampulla, ampullaryisthmic junction and the isthmus (Ellington, 1991). Upon
release from the ovulatory follicle, the oocyte is captured

by the infundibuliam and transported to the ampulla. Later

stages of oocyte maturation occur in the ampulla, while

sperm capacitation occurs in the uterus and isthmus of the
oviduct as gametes travel toward one another. At the

ampullary-isthmic junction, a capacitated sperm binds and
subsequently penetrates the zona pellucida of the matured

oocyte. Fertilization of a mature ovum results in the
formation of a zygote. Cleavage and subsequent development

of the embryo continue in the isthmus until the 8- to 16cell stage (Figure 1) when the embryo enters the uterus

(Ellington, 1991; for review see Bazer et al., 1993).
Ninety-six hours after fertilization (approximately 5

days following onset of estrus), the embryo is referred to
as a morula. Prior to the 8-16 cell stage, the early embryo
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Figure 1. Location and time of embryonic development in the
cow. Reprint permission granted by Dr. Rod Geisert, Oklahoma
State University.

relies on messenger ribonucleic acids (rtiRNAs) and proteins
of maternal origin for development. However, in order for
the embryo to proceed in development, the embryonic genome
must "switch on" to produce proteins needed for further

development (Barnes and First, 1991).
Cleavage and development continue in the uterine horn

ipsilateral to the CL where the embryo must advance through
the compaction process (for review see Betteridge, 1988).
During compaction, the morula forms a tight ball of cells in
which the blastomeres (cells comprising the early embryo)

adhere to and flatten against one another so that individual
cell outlines are no longer visible (Pratt et al., 1982),

The outermost layer of cells polarize and subsequently form
the trophectoderm (Koyama et al., 1994) whereas the inner
cells of the morula remain apolar and form the inner cell

mass (ICM; Kimber et al., 1982). Outer cells form tight

junctions with one another to form a barrier (Fleming et
al., 1989). These junctions allow fluid to be moved into the

embryo by active ion transport via the Na+/K+ ATPase pump to
form the blastocoele (for review see Wiley et al., 1990).

Inner cells form gap junctions to allow cell to cell
communication. This arrangement of cells allows for

development of the 3 germ layers: endoderm, mesoderm,
ectoderm (for review see Bazer et al., 1993).

The ICM forms the embryo proper while the trophectoderm
forms the extra embryonic membranes (for review see Bazer et
al., 1993). Eight to 10 days after ovulation, the embryo
"hatches" from the zona pellucida (Figure 1) due in part to

the expansion of the blastocoele. During hatching, the zona

layer becomes torn on the equatorial plane and the embryo
exits through the opening.

Between days 15 and 19 of development, the bovine

embryo must produce a signal to prevent PGF2a-mediated
regression of the CL (Northey and French, 1980). This
phenomenon has been classically referred to as maternal
recognition of pregnancy (for review see Thatcher et al.,
1995). Cattle and sheep embryos produce a protein known as

bovine trophoblast protein (bTP-1) and ovine trophoblast

protein (oTP-1), respectively (Helmer et al., 1987). Ovine
trophoblast protein is synthesized by bovine trophectoderm
from days 16-24 of pregnancy (Thatcher et al., 1989; Roberts
et al., 1992). Godkin et al. (1982) reported pulses of PGF2„

necessary for luteolysis were blocked due to binding of oTP1 to surface glandular epithelial cells of the endometrium.
These proteins are also referred to as interferon-tau (IFNi; Roberts et al., 1992). Interferon-i disrupts the

cyclooxygenase enzyme complex by inducing an intracellular
endometrial inhibitor (Gross et al., 1988). Interferon-i

also down regulates the nioinber of oxytocin receptors in the
endometrium of the uterus; therefore, interrupting the

feedback loop of luteal regression (Flint, 1989).

Embryonic loss

As defined by the Committee on Reproductive

Nomenclature (1972), embryonic mortality is any loss which

occurs during the first 42 days of pregnancy. Failure of
normal embryonic development or luteal dysfunction are

possible reasons for embryonic loss. Another possible cause
includes a hostile uterine environment which may be

detrimental to the embryo or CL. Fertilization rates of 90
to 95% are considered normal. Pregnancy rates, however, may
be as low as 50-60% (Sreenan and Diskin, 1983).

Embryonic loss has been estimated to be between 20
(Ayalon, 1978) and 42% (Diskin and Sreenan, 1980). The
greatest percentage of embryonic mortality in cattle occurs
before day 18 after mating (Sreenan and Diskin, 1986).
Additional studies have narrowed this time frame to before

day 8 (Ayalon, 1978; Maurer and Chenault, 1983). Ayalon
(1978) reported that the majority of embryonic loss occurred
during the transformation from morula to blastocyst or

between days 6 and 7. On the other hand, Diskin and Sreenan

(1980) reported that the majority of embryonic loss occurred

during maternal recognition of pregnancy (days 16 to 18).

Synthesis of PGFja

Prostaglandin Fza is a metabolic product of arachidonic
acid. Arachidonic acid is a fatty acid which may be obtained
from the diet or membrane lipids, which is converted from

linoleic acid by desaturase enzymes (Moore, 1985). Several

pathways exist for production of prostaglandins through the
arachidonic acid cascade (reviewed by Milvae, 1986).
After release of arachidonic acid, two predominate

pathways exist (Figure 2). The first, less efficient pathway
involves production of hydroxyacids and leukotrienes through
a lipooxygenase enzyme (Norman and Litwack, 1987). The

second pathway is the most efficient of the two and includes
the production of thromboxanes and prostaglandins through
the cyclooxygenase enzyme. Through this mechanism,

phospholipase A2 can attach membrane phospholipids to
release arachidonate which in turn may be acted upon by

either prostaglandin endoperoxide synthase or cyclooxygenase
(Norman and Litwack, 1987).

Aspirin and indomethacin are effective in preventing
prostaglandin production through inhibition of

Phospholipid

i

Phospholipase Aj

Arachidonic Acid

Cyclooxygenase I PG endoperoxide synthase
Prostaglandin Gj

I

PG endoperoxide synthase

Prostaglandin H2
PG endoperoxide reductase

Prostaglandin
Figure 2. Schematic representation of PGF2c( synthesis.
(Norman and Litwack, 1987)

cyclooxygenase (Vane, 1971). In addition, aspirin,
indomethacin, and flunixin meglumine are all potent

inhibitors of endoperoxide synthase (Vane, 1971).

Prostaglandin Fza is metabolized very quickly through a

single passage of the lung by 15-prostaglandin dehydrogenase
to the inactive metabolite, 13,14-dihydro-15-keto

prostaglandin F2„ (PGFM; Kindahl et al. 1976). Kindahl et
al. (1976) reported a direct relationship between PGFzc and
PGFM in cattle. However, Carver (1989) reported that
concentrations of PGFM in blood from the jugular or

posterior vena cava did not accurately reflect the
production of PGFzc by the uterus in cattle. Nonetheless,
PGFM concentrations are used routinely as an indicator of

peripheral PGFzc concentrations.

Mechanism of action of PGFzc

The corpus luteum is an extremely vascular endocrine

gland responsible for the maintenance of pregnancy through

production of progesterone. The CL is comprised of two cell
types varying in size. Size differences have resulted in
cells of the CL being referred to as "small" (^20 mm) and

"large" (>20 mm) luteal cells. Large luteal cells are
responsible for the production of the majority of

progesterone found in blood. However, small cells appear to
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facilitate production by large cells. Regression of the CL
has been reviewed in the literature at great length (Milvae

et al., 1986; Knickerbocker et al., 1988; Silvia et al.,
1991; Niswender et al., 1994; Pate, 1996).

The CL receives up to 80% of the blood flow to the

ovary in ewes (Nett et al., 1976). Prostaglandin F2„, a

potent vasoconstrictor, decreased blood flow to the ovary
during luteolysis in ewes (Nett et al, 1976). It is not
known whether this is a symptom or a cause of luteal

regression. Furthermore, PGF20 plays both an

antisteroidogenic and a cytotoxic role in luteal regression.
Receptors for PGF2a have been isolated on large luteal
cells throughout the bovine estrous cycle (Wiltbank et al.,

1995). The PGF2a receptor is a seven transmembrane G-protein
linked receptor (Sakamoto et al., 1995).

Pate (1996)

hypothesized that large luteal cells are the target of
uterine PGF20,. However, administration of PGF2C generally is
not successful to induce luteal regression in the cow prior

to day 5 post-estrus. The presence of PGF2a receptors

implies that other factors are not present to complete the

pathway of luteal regression during the early estrous cycle.
During luteal regression, PGF2a is secreted in a

pulsatile fashion by uterine endometrial tissue (reviewed by
Milvae, 1996). Prostaglandin F2a reaches the iplsilateral CL
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by a local veno-arterial countercurrent transfer system
(Hixon and Hansel, 1974). Prostaglandin F2„ stimulation
causes release of oxytocin (OT) from large luteal cells
(Flint and Sheldrick, 1982). Oxytocin binds to endometrial

OT receptors to stimulate release of PGF2a at approximately
6 hour intervals (as reviewed by Silvia et al., 1991)

initiating the 0T-PGF2a feedback loop and pulsatility of
PGF2a release.

When luteal receptors bind PGF2„, receptors are
translocated across the membrane and cause activation of

phospholipase C (PLC; Davis et al., 1987). Phospholipase C
causes hydrolysis of phosphatidylinositol 4, 5-bisphosphate

(PIP2) to inositol-1,4,5-triphosphate (IP3) and 1,2diacylglycerol (DAG; Berridge, 1987). Diacylglycerol
increases the affinity of protein kinase C (PKC) for calcium

while IP3 causes release of calcium from intracellular
stores. The end result is a dramatic increase in free
intracellular calcium concentrations and activation of PKC

(reviewed by Nett et al., 1976).
This increase in intracellular calcium concentrations

has been implicated in the cytotoxic effect of PGF20, by

stimulating apoptosis to occur. Apoptosis is characterized
by condensation of chromatin, compacting of cytoplasmic
organelles, formation of vesicles on the cell membrane
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surface, and specific DNA degradation into regularly sized

fragments (Rueda et al., 1995). The cleavage of DNA, a
characteristic of apoptosis, may be determined by end

labeling with ^^P-labeled dideoxy-adenosine triphosphate and
the presence of a DNA ladder. This DNA ladder has been
identified in the CL at luteolysis and is similar to that
observed in other cases of apoptosis (McGuire et al., 1994).
Furthermore, DNA laddering was observed in luteal tissue at

days 8, 10, and 12 of the estrous cycle in ewes treated with

PGFzc but not in controls. Both control and PGFjc-treated
ewes had DNA laddering at day 14 of the estrous cycle

(period of normal luteolysis; Rueda et al., 1995).
Therefore, PGF2a appears to exert a cytotoxic effect on
luteal cells by increasing intracellular calcium
concentrations and stimulating apoptosis.

The antisteroidogenic effect of PGFja is primarily
exerted by activation of protein kinase C (PKC). Protein
kinase C inhibits cholesterol transport to the mitochondria
where the P450 side chain cleavage enzyme awaits to convert

cholesterol to pregnenolone (Norman and Litwack, 1987). In
rats, treatment with PGFjc resulted in a decrease in plasma
membrane fluidity and an increase in superoxide radical
formation (Sawada and Carlson, 1991). Synthesis of the

superoxide radical is controlled by the PKC-second messenger
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system (Sugino et al., 1996). Wu et al. (1992) reported that
the superoxide radical inhibited LH stimulation of cAMP and
decreased activity of protein kinase A (PKA); therefore,

decreasing the presence of cholesterol in the mitochondria
and ultimately decreasing the production of pregnenolone.
Prostaglandin Fza has been reported to reduce steady-state
levels of mRNA for 3beta-hydroxysteroid dehydrogenase, thus

decreasing the conversion of pregnenolone to progesterone.
Thus, PGF2a may exert its antisteroidogenic effect of

decreasing progesterone production through multiple
pathways.

Prostaglandin Fja association with embryonic loss

The negative effect of prostaglandin F2„ on embryonic
development was first reported in the rabbit. Stormshak and
Casida (1965) reported progesterone could prevent abortion,
but not fetal death in rabbits, when estrogen was used to

rescue the corpus luteum from LH-induced luteolysis.

Increasing concentrations of PGF2a increased the number of
fetal deaths and treatment with progesterone prevented
abortion but not fetal death in mice (Harper and Skarnes,
1972).

Premature release of PGF2a has been associated with
first ovulation in the postpartum cow and leads to a

15

decrease in length of the luteal phase (Ramirez-Godinez et
al., 1981; 1982; Peter et al., 1989; Cooper et al., 1991).
Cows bred at their first postpartum ovulation failed to
maintain pregnancy even when exogenous progestogen was

provided to replace the regressing CL (Breuel et al.,
1993b). Schrick et al. (1993) transferred day-6 embryos from
cows with short luteal phases into normally cycling

recipients and reported that pregnancy could be maintained,
indicating that changing the uterine environment allowed
embryonic development beyond that of the postpartum cow.

However, when "good" quality embryos were transferred into
cows with short luteal phases and supplemented with

exogenous progesterone, pregnancy rates were 50% lower than
in cows with normal luteal phases (Butcher et al., 1992).

This study implies a hostile uterine environment may have
toxic effects on embryonic development.

Schrick et al.

(1993) reported elevated concentrations of PGFzc in the

uterine lumen of postpartum cows compared to normal cycling
cows. Cows with higher PGFjq concentrations had lower
quality embryos (r= -0.42, P=0.07). Therefore, PGF2„ was

implicated in playing a direct role in decreasing embryonic
survival in postpartum cows as demonstrated in mice (Harper
and Skarnes, 1972).
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Prostaglandin Fja has been shown to have a direct

effect on embryos from other species also. Maurer and Beier
(1976) reported that culture of rabbit embryos in PGFzc

(0.1-10 ng/mL) had no effect on development to blastocyst,
but decreased continued development to expanded or hatched

blastocyst. Breuel et al. (1993a) found that 0.1-10 ng/mL of
PGFzc in culture media prevented development of 8-cell rat
embryos to morula and blastocyst. However, in vivo
administration of PGF20, in progestogen-supplemented rats

from days 4 to 9 did not result in a decreased number of

implantation sites (Buuck, 1997). The author hypothesized
that the rat may not be a good model for the cow due to the

presence of 9-keto-reductase which catalyzes conversion of
PGFza to PGE2. Furthermore, rat embryos compact as early as
the 8-cell stage as opposed to the cow which undergoes

compaction around the 32-cell stage. Breuel et al. (1993a)

reported blastocyst stage embryos were recovered in control
media after 24 h in culture (day 5 of pregnancy), however,

bovine embryos do not reach blastocyst stage until

approximately day 7 of pregnancy. Therefore, the window of
time during which embryos are susceptible to the deleterious
effects of PGF20, may be smaller in the rat than in the cow.
In early postpartum cows supplemented with exogenous

progesterone and injected with either saline, flunixin
17

meglumine, or flunixin meglximine plus lutectomy, pregnancy

rates were higher in cows receiving flunixin meglumine plus
lutectomy. Normal cycling cows supplemented with

progesterone and administered PGFza during days 4-7 or days
5-8 after mating had lower pregnancy rates than saline or

flunixin meglumine treated cows (Buford et al., 1996).
Furthermore, lutectomy immediately prior to PGFsc treatment

prevented embryonic loss. Similarly, Seals et al. (1998)
reported that PGFza administration to progestogensupplemented cows between days 5-8 decreased pregnancy rates

compared to saline. The same treatment had no effect on

pregnancy rates if administered between days 10-13 or 15-18.
Pregnancy rates were increased in PGF2c-treated cows
receiving exogenous progestogen if lutectomy was performed
on day 5 before treatment was initiated.
To further delineate the timing of PGFjc, toxicity, day-

7 frozen-thawed embryos of good or excellent quality were

cultured in media containing 0, 0.1, 1.0 or 10 ng/mL PGF2a
(Fazio and Schrick, 1997).

Percent development to

blastocyst did not differ between control media (0), 0.1, 1,
or 10 ng/mL treatments after 72 h of culture. Transfer of
day-7 embryos to cows administered PGFjc, and exogenous

progestogen resulted in pregnancy rates similar to those of
control animals (E. K. Inskeep, personal communication).

18

However, Hernandez-Fonseca et al. (1997) reported that

transfer of day 6 embryos to cows administered PGF2a and
exogenous progestogen resulted in decreased pregnancy rates
compared to cows receiving saline. Thus, these experiments
narrowed the window of PGFjc toxicity on the bovine embryo

to prior to day 7 following mating.
These trials offer several suggestions regarding the

embryotoxicity of PGFj^. Effects of PGFzc in cycling cows may
be seen early in embryonic development (between days 4-7 or

days 5-8 post mating) but not after day 10 post mating or
after day 7 in vitro and in vivo. Lutectomy increased

pregnancy rates in progestogen-supplemented cows receiving
PGFzc suggesting that the regressing CL may be deleterious
to embryonic survival. This observation is further supported
by work in the rat (Buuck, 1997) where culture of embryos
with both PGF2a and the luteal tissue further retarded

embryonic development below that of PGF2a alone. This study
implies that some factor from the regressing CL could have
toxic effects on embryonic development.

Oxytocin is known to be released from the CL during
normal luteolysis caused by PGF2a administration (Flint and
Sheldrick, 1982; Schallenberger et al., 1984; Stormshak et

al., 1994 ). Injection of oxytocin on days 5-8

in cycling

beef cows supplemented with exogenous progestogen with or
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without the presence of a CL decreased pregnancy rates

(33%

and 30%, respectively) compared to saline (80%) (Lemaster et
al., 1998). However, administration of oxytocin and flunixin

meglumine restored pregnancy rates equal to that of control
animals. Therefore, oxytocin does not appear to directly
affect embryonic development and any indirect effects may be
restored by preventing PGFjc production. Also, the fact that

oxytocin can decrease pregnancy rates in luctectomized
animals rules out other "toxic factors" being produced by
the regressing CL and promotes PGFja as the embryotoxic
factor.

Events initiating PGFjc secretion

Many situations exist where concentrations of PGFza may
be elevated and cause detrimental effects on embryonic

development. For example, dairy cows in today's high
production scenario may be extremely susceptible to
elevation of PGFzc,.

Butler (1998) noted that cows in

negative energy balance had higher levels of uterine PGFzc
and may have an increased sensitivity for release of PGFzc,.
Also, many producers have adopted the practice of
administering oxytocin to improve milk letdown and

production. Farin and Estill (1993) noted that oxytocin
administration resulted in elevated levels of PGFj^, and an
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increase in the nviit±>er of short cycles. Therefore,

administering oxytocin on a regular basis may result in CL
regression and/or elevated concentrations of uterine PGF2„
which may be directly detrimental to the early embryo.

Prostaglandin F2a may also be elevated during mastitis.
Elevated concentrations of PGF2a have been reported in milk
from cows with Gram-negative mastitis (Giri et al., 1984).
Furthermore, intrauterine infusion of endotoxin (Gilbert et

al., 1990) resulted in shortened estrous cycles. Therefore,
dairy cows in negative energy balance and administered

oxytocin, or experiencing clinical mastitis caused by a
Gram-negative pathogen may have elevated concentrations of
PGF2a which may negatively affect embryonic development.
Beef cows are also at risk for elevated concentrations

of PGF2a and decreased reproductive efficiency. In addition
to those scenarios discussed with dairy cows, beef cows may

be subject to elevated PGF2C, due to grazing endophyteinfected tall fescue. Cows consuming endophyte-infected tall
fescue have elevated levels of PGFM in plasma (Seals et al.,
1998).

Additionally, PGF2„ may be released in either dairy or
beef cows due to uterine manipulation associated with
artificial insemination or embryo transfer (Schallenberger

et al., 1989).

Both dairy and beef cows experiencing heat

21

stress are characterized as having elevated PGFza

concentrations of PGF2a (Malayer et al., 1990). Therefore,
the interaction of endophyte-infected fescue consumption and
mastitis or heat stress may compound the elevation of PGFza
concentrations.

Thus, PGFze, is commonly elevated in both beef and dairy
cows. Elevated concentrations of PGFj^ are often associated

with decreased reproductive efficiency, namely decreased

pregnancy rates. Research has indicated that PGFjc may have
a direct negative effect on pregnancy rates.
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3. STATEMENT OF THE PROBLEM

Embryonic mortality results in direct economic losses
to beef and dairy producers. The estimated cost of wintering

open beef cows in the United States is $1.1 billion annually
(Inskeep and Peters, 1982). Dairy producers experience a
loss of $1.50 to $2.00/head for each day a cow is open past

90 days of production (Graves, 1987).
Increased embryonic mortality may in part be due to

elevated PGFjc resulting from manipulation of the

reproductive tract during embryo transfer or that which
occurs during disease states such as mastitis (Giri et al,,
1984) or fescue toxicosis (Seals et al., 1998). Schrick et

al. (1993) reported that elevated uterine concentrations of

PGFja in postpartum cows were correlated inversely to embryo
quality.

Moreover, PGFzc administration from days 4-7 or 5-8

following insemination decreased pregnancy rates in cows
that were supplemented with progesterone (Buford et al.,
1996; Seals et al., 1998). Pregnancy rates were similar for

cows supplemented with progesterone and treated with PGFjc

during days 7-9 and receiving a day-7 embryo (E. K. Inskeep,

personal communication). However, recipient cows treated
with PGFjc on days 6-8 and receiving exogenous progestogen
exhibited decreased pregnancy rates when day-6 embryos were
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transferred into the uterine horn ipsilateral to the CL
(Hernandez-Fonseca et al., 1997).

Negative effects of PGF2a may be due to direct effects
on the early embryo or as a result of alterations in the
uterine environment. To test the hypothesis that PGFzq

negatively affects early embryonic development, an

experiment was designed to evaluate embryo quality and
development in cycling cows receiving either PGF2a or saline
during days 5-8 postbreeding while being supplemented with
progestogen.
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4. M2^TERIALS AND METHODS
General methods

Estrus was synchronized in cycling beef cows (n=70)

using a Syncro-Mate B (Rhone Merieux, Athens, GA)/Lutalyse
(Pharmacia and UpJohn, Kalamazoo, MI) protocol (Figure 3).
Cows were administered a 6 mg norgestomet implant and

injected intramuscularly with 3 mg norgestomet and 5 mg
estradiol valerate. Implants were removed nine days later
and cows were administered 25 mg PGFjc intramuscularly

(Lutalyse). Cows were fitted with Heatwatch ® heatmount
detectors (DDX, Boulder, CO) for estrous detection in
addition to visual surveillance twice daily. Cows were bred

artificially at estrus (d 0) and again 12 h later using one
Holstein bull of known fertility to remove any "male"
effect. All cows were fed 4 mg of melengestrol acetate (MGA;

1 mg MGA per .45 kg pelleted feed. Appendix A; Tennessee
Farmers Cooperative, Knoxville, TN) beginning on d 3 (Seals
et al., 1998). Cows were allowed ad libitum access to

bermuda grass pasture, orchard grass hay and water.
Additional feed was provided for supplemental energy.

Experimental procedures

Cows were assigned randomly to receive either 3 ml
saline (CON) or 15 mg PGF2„ (TRT) at 0600,1400 and 2200 h
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Figure 3. Schematic design of experiment

beginning on d 5 through 0600 h on d 8 (Figure 3).
Ultrasonography was performed immediately prior to treatment
on d 5 with an Aloka 500 ultrasound unit equipped with a 7.5
MHz linear transducer (Model UST-556I-7.5, Corometrics

Medical Systems, Wallingford, CT). Ultrasonography was
performed to verify the presence and location of the CL
before initiation of PGFjc treatment and regression of CL.

Embryo recovery and evaluation

A single embryo was recovered by flushing the uterine
horn ipsilateral to the CL with 1 L of Dulbecco's phosphate
buffered saline (PBS; Gibco, Inc., Grand Island, NY)

containing 1% fetal calf serum (FCS; Gibco, Inc.). Uterine
flushes were scored (range 1-3) on each cow with regards to

the difficulty and amount of uterine manipulation required.
A flush score of 1 was indicative of an easy flush with very

little manipulation and 3 was an extremely difficult flush
with excessive manipulation.
Flush media (3 mL) were collected from the second

passage of medium through the uterine horn of each cow.
Flush samples from cows with a flush score of 1 or 2 were
used for analysis of PGF2a and 13, 14-dihydro-15-keto-

prostaglandin Fza (PGFM). The remainder of the collected
flush medium was filtered through a 0.22 micron filter
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(Veterinary Concepts Incorporated, Spring Valley, WI) and
searched for the presence of an embryo. Embryos were removed
and placed into a holding medium (PBS with 15% FCS), scored
for quality following the scheme proposed by Elsden and
Seidel (1982), and stage of development was recorded.

Quality scores were assigned by two experienced technicians
unaware of treatment as follows:

Quality score 1: Perfectly symmetrical inner cell mass,
evenly granulated, evenly colored with no serious
deformities in the zona pellucida and at least 85% of the
cell mass intact. Stage of maturity corresponded to the
stage expected for the day of collection.

Quality score 2: Slight variation of all the above in
quality score 1, may have several extruded blastomeres but
one definite healthy large cell mass existed that contained
50% or more of the entire mass. Maturity was near stage of

development expected on the day of collection.

Quality score 3: May have irregular zona pellucida,
discolored or retarded development, but at least one heathy
cell mass that contained 25% or more of the entire cell
mass.

Quality score 4: Degenerated, retarded, or dead embryo.
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Blood preparation and radioimmunoassays

Jugular blood (12 ml) was collected prior to
administration of treatments at 0600 and 2200 and placed in

chilled tubes containing 200 /Ul sodium citrate

(25 mg/ml of HjO; Baxter Scientific Products). Blood and
flush samples were placed on ice until processing at the

laboratory. Blood samples were centrifuged (2500 x g) for 20
min and plasma was collected. Plasma and uterine flush

samples were stored at -20°C until radioimmunoassays were

performed. Plasma samples were assayed to determine
concentrations of progesterone (P4) and PGFM. Uterine flush
samples were assayed for PGFzc and PGFM.

Progesterone concentrations in plasma were determined
using a solid phase radioimmunoassay (Diagnostic Products

Corp., Los Angeles, OA) as described by Seals et al. (1998).
Sensitivity of the assay was 0.02 ng/mL. Intra- and interassay coefficients of variation were < 5%.
Concentrations of PGFM in plasma and flush media were

determined as described by Silvia and Taylor (1989) with
modifications described by Romanics and Silvia (1988).

Sensitivity of the assay was 15 pg/tube (200 ^il) and the
intra-assay coefficient of variation was < 5%. Antibody for
the PGFM assay was provided by William Silvia, University of
Kentucky, Lexington.
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Prostaglandin Fza concentrations in uterine flush

samples were determined by the procedure of Cooper et al.
(1991). Sensitivity of the assay was 25 pg/tube, with an

intra-assay coefficient of variation (CV) of <10%.

Statistical analysis

Changes in concentrations of P4 and PGFM were compared

by analysis of variance for a split-plot design with
treatment as the main plot and time as the subplot using the

MIXED procedure of SAS (1997). Relationships between uterine
PGFM, uterine PGF2C, and embryo score were determined using
Proc Corr of SAS (1997). Embryo scores and embryonic

development were analyzed by Fisher's Exact Test (SAS
Institute, 1997).
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5. RESULTS AND DISCUSSION

Hormone analysis

Overall progesterone concentrations were lower in TRT

versus CON cows (0.3 ± 0.14 vs 2.01 ± 0.16 ng/mL,
respectively; P=0.0001). Furthermore, treatment affected
progesterone concentrations over time. Progesterone
concentrations increased in CON animals over time,
characteristic of normal luteal function. Animals

administered PGF2a exhibited decreased progesterone over
time as would be observed during luteal regression (Figure
4; P=0.0001). Furthermore, cows in the TRT group had

elevated overall PGFM concentrations (553.17 ± 42.05 pg/mL)

compared to CON (13.17 ± 50.09 pg/mL; P=0.0001). The
interaction of time and treatment affected significantly
PGFM concentrations with PGFM concentrations remaining

steady in CON cows but increasing over time in TRT cows
(Figure 5; P=0.0001).

These results are complimentary to those of Seals et

al. (1998) who performed a similar experiment except looking
at pregnancy rates instead of actual embryo development and

quality. The administration of PGF2C resulted in elevation
of PGFM, the metabolized form of PGF2e,. Additionally, PGF2a

administration caused subsequent luteolysis and resulted in
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in PGFM concentrations between treatments

decreased progesterone concentrations in TRT cows.
Uterine liaminal concentrations of PGF2a in flush medium
did not differ between CON and TRT cows (818.98 ± 81.57 vs

780.87 ± 103.98, respectively; P=0.78). Uterine luminal PGFM
concentrations also did not differ between CON and TRT cows

(79.81 ± 37.97 vs 136.39 ± 32.09, respectively; P=0.26).

These data are not surprising. The technique for collection
of uterine lumen samples to determine concentrations of

PGFjc is not the most optimum technique. Manipulation of the

reproductive tract cannot be avoided during passage of the
catheter through the cervix and placement in the uterine
horn. Therefore, release of PGFzc is unavoidable by this

technique. However, samples from cows with excessively
difficult flushes were not analyzed for PGF2„ or PGFM
concentrations to decrease some effects uterine manipulation

might impose. The preferred method of sampling would include
death of the animal, removal of the reproductive tract from

the animal, and flushing the tract with saline.

Embryo recovery

Following synchronization, 58 of 70 cows exhibited
estrus. Uterine flushes were attempted on 58 cows and 52

attempts were successful to completion. Six flushes were not
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completed due to inability to pass the cervix or inhalation
of air into the uterus.

Embryo recovery was successful in 28 of 52 flushes
(54%). Of this total, 3 unfertilized ova and 1 zona

pellucida were found. Samples from these animals were not
included in data analysis. Out of the 52 cows which were
successfully flushed, 24 were CON yielding 13 successful
recoveries (54.2%) and 28 were TRT yielding 15 successful
recoveries (53.6%).

One hypothesis raised in the past was that PGFzc may

speed passage of the embryo through the uterine horn and
thereby have a negative effect on development and pregnancy
rates. Fuchs (1987) suggested that uterine motility and

gamete transport are accelerated by either PGFjc, or OT. Our
recovery percentages suggest that embryos did not travel
down the uterine horn at differing rates in TRT and CON cows
to the point of altering recovery.

Development and quality scores of embryos

One objective of this experiment was to determine if
administration of PGFzc had a negative effect on development

and quality of embryos between days 5-8 of pregnancy in cows
supplemented with exogenous progestogen. Evaluation of
quality scores and development of collected embryos
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indicated that elevated concentrations of PGF201 decreased
development and quality of embryos. Embryo quality scores
revealed an increase in mean quality scores in TRT compared
to CON cows (2.9 ± 0.30 vs 1.6 ± 0.35, respectively;
P=0.059) indicating a reduction in the quality of TRT

embryos. Percentage of embryos at each stage of development
differed between treatment groups (Figure 6, Fisher's Exact

Test P=0.003). Although 29% (4/14) developed to expanded
blastocyst, 64% (9/14) had not developed past the morula
stage. Furthermore, 80% (8/10) of the CON embryos progressed

to expanded blastocyst and 20% (2/10) of the embryos were at
the

blastocyst stage upon recovery. All CON embryos had

developed to maturity corresponding to day of development.
Percentage of embryos at each quality score differed

between treatments (Figure 7, Fisher's Exact Test P<0.003).

Quality score 1 embryos comprised 60% (6/10) of CON embryos
compared to 29% (4/14) of TRT embryos. Furthermore, 64%
(9/14) of TRT embryos were quality score 4 while none of the

CON embryos were quality score 4. The appearance of embryos
in the TRT group with a quality score of 4 were noted as

having dispersed cells with a fragmented (dark salt and

pepper) appearance. Therefore, treatment with PGF2a resulted
in a lower percentage of embryos being excellent in quality
and a greater percentage of embryos being poor in quality.
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These results complimented those of Seals et al, (1998)

which reported a decrease in pregnancy rates in progestogen
supplemented cows administered PGFjc,. The pregnancy rates
(71% CON, 23% PGFza) reported by Seals et al. (1998) are
similar to the percentage of embryos found to be of good or
excellent quality.
Embryos with a quality score of 1, 2 or 3 are
considered viable and worthy of transfer to recipient cows.

Comparison of CON and TRT embryos on this basis resulted in

100% (10/10) of CON embryos considered transferrable
(viable, quality score 1, 2, or 3) while only 36% (5/14) of
TRT embryos were considered transferrable (P=0.002).

However, 64% (9/14) of TRT embryos lacked development and/or
quality to be considered viable for embryo transfer.
A positive correlation between embryo quality score and
PGFM concentrations on day 8 at 0600 h (r=0.47, P<0.05) and

on day 8 at time of flush (r=0.74, P=0.0001) was observed.
Additionally, uterine luminal concentrations of PGFM tended
to be related to embryo quality score (r=0.38, P=0.07). In
contrast, no relationship was observed between uterine
luminal concentrations of PGFjc and embryo score (r=0.18,
P=0.41). Uterine concentrations of PGF2a and PGFM were

highly correlated to one another (r=0.75, P=0.0001). The
significance of the correlation of uterine luminal PGFM
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concentrations with embryo score is unknown. At present, no

reports have been published to evaluate effects of PGFM on

embryonic development, although the possibility does exist
that high concentrations of PGFM could have a detrimental
effect on embryos.

Although very little research has been performed in the
area of PGF2a and embryonic development, several mechanisms

may account for negative effects of PGF2„ on embryonic
development. Prostaglandin F2„ stimulates calcium influx
into cells (for review see Niswender et al., 1994). This is

the mechanism which is responsible for apoptosis of luteal

cells during regression. During luteal regression, PGF2a
binds to its receptors and stimulates PLC and subsequent
release of IP-3 (Davis et al., 1987). Inositol tri-phosphate
causes mobilization of intracellular stores of calcium into

the cell. Calcium then stimulates Ca^'^/Mg^"' dependent
endonucleases to cut DNA into internucleosomal fragments

(Rueda et al., 1995). These fragments form the
characteristic DNA ladder used as a landmark for apoptosis.

Prostaglandin Fza administration to ewes induced DNA

fragmentation in luteal tissue (Rueda et al., 1995).
Presence of PGF2„ receptors on the surface of the embryo or
individual blastomeres has not been reported. The presence
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of PGFza receptors may be a requirement for PGFza to

negatively affect embryos through this proposed mechanism.
Also observed during CL regression is the production of

reactive oxygen species (for review see Niswender et al.,
1994). Free radicals may work much like elevated levels of
intra-cellular calcium to degenerate DNA into fragments or

by attacking the integrity of the cell membrane (Wagner et
al., 1996; Thomas et al., 1997). Furthermore, free radicals

may modify low density lipoprotein (LDL) by oxidation to
produce a toxin. The molecule 7 beta-hydroperoxycholest-5en-3 beta ol (7 beta-OOH-Chol) has been purified and is

responsible for 90% of the cytotoxicity of the lipids of
oxidized LDL (Chisolm et al., 1994). This compound has been
found in hioman atherosclerotic lesions and the plasma of

diabetic animals, and it may play a role in tissue damage
that occurs in certain diseases (Chisolm et al., 1994). The

period of luteal regression may be vulnerable to this
mechanism as LDL is abundant on the surface of luteal cells

and free radical production occurs during this time frame as
well. The initiation of luteal regression by injection of

PGF2„ may stimulate this pathway to produce a cytotoxic
component.

Two other possible mechanisms by which PGFzc may

interrupt embryonic development include disruption of gap
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junction formation and function. Cadherins and connexins are
two proteins vital to cell communication and gap junction
formation. Cadherins are a member of a family of cell

adhesion molecules (CAM). Epithelial cadherin (E-cadherin)
is seen on the cell surface of epithelial cells. E-cadherin

allows cells of like type to adhere to one another. This is

most important during the process of compaction. Embryonic
cells adhere to one another and gap junctions are opened
which allow cells to communicate with one another.

Blastomeres then organize according to polarity and
function. Furthermore, outer cells form tight junctions

which are necessary for cell support, a function most

important when uterine fluid is pumped into the embryo to
form the blastocoel.

Culture of myoctes from neonatal rat hearts in

arachidonic acid, a precursor to prostaglandin synthesis,

has produced reversible uncoupling of gap junctions
(Schmilinsky et al., 1997). Crow et al. (1994) reported that
culture of bovine embryonic lens cells with two different

ionophores caused an increase in intracellular calcium
concentrations and decreased intracellular dye transfer.

Connexins are proteins which make up the channels of

the gap junction. At present, 13 subgroups exist which have
been identified (DeSousa et al., 1997). Connexin 43 has been
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identified and studied in the mouse embryo. Koo et al.

(1997) reported that phosphorylation of connexin 43 on
serine residues correlated with a decrease in gap junctional
communication in clone 9 rat liver cells. Connexin 56, the

lens gap junction protein, has been shown to be modified
through phosphorylation by protein kinase C or protein
kinase A in vitro (Berthoud et al., 1997). Both protein

kinase C and protein kinase A are products of PGFjc binding
to its receptor. Phosphorylation of connexins decreases

opening of gap junctional channels and therefore decreasing
cell communication. Protein kinase C, which is elevated

during times of luteal regression, is capable of

phosphorylating connexins. Gap junctional intercellular
communication between luteal cells is decreased by culture

with a PKC agonist (TPA, Grazul-Bilska et al., 1996).

Conclusion

In summary, results of the current experiment indicate

that PGF2„ has a detrimental effect on embryonic development

by decreasing the rate or ability of an embryo to develop
past the morula stage. Additionally, PGFzc decreased the
quality score of embryos recovered on day 8 and quality
scores were highly correlated to blood PGFM values and
tended to be related to PGFM in uterine flush samples.
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Prostaglandin Fza may interfere with the process of
compaction which occurs at the morula (16-32 cell) stage in
the bovine. Future studies should be aimed at delineating

mechanisms by which PGFjc exerts a negative influence on
quality and development of the early bovine embryo.
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Ingredients

Processed grain by-products, plant protein products, grain
products, forage products, cane molasses, calcium carbonate,
salt, lignin sulfonate, potassium sulfate, magnesium
sulfate, zinc oxide, manganese oxide, ferrous sulfate,

magnesium oxide, copper sulfate, cobalt carbonate, ethylene
diamine dihydroiodide, calcivim oxidate, sodium selenite,

vitamin A acetate, vitamin D-3, vitamin E supplement and
mineral oil.

Guaranteed Analysis

Crude protein (min.)

25.00%

Crude fat (min.)

2.50%

Crude fiber (max.)

9.75%

Phosphorus (min.)

0.55%

Calcium (min.)

1.25%

Salt (min.)
Potassium (min.)

1 • 30%
1.00%

Vitamin A (min.)
Vitamin D (min.)

5,000 lU/lb
1,500 lU/lb
Active Ingredient

Melengestrol Acetate

2,000 mg/ton
Manufactured By

Tennessee Farmers Cooperative
200 Waldron Road

Lavergne, TN 37086
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